newsfilter
← Latest News
GlobeNewswire·

CytomX Therapeutics to Report First Quarter 2025 Financial Results on May 12, 2025

SOUTH SAN FRANCISCO, Calif., May 05, 2025 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (NASDAQ:CTMX), a leader in the field of masked, conditionally activated biologics, today announced that it will report first